Comparative Pharmacology
Head-to-head clinical analysis: CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE versus MENRIUM 10 4.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE versus MENRIUM 10 4.
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE vs MENRIUM 10-4
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Chlordiazepoxide is a benzodiazepine that enhances GABA-A receptor activity, increasing chloride ion influx and causing CNS depression. Clidinium bromide is an anticholinergic that blocks muscarinic acetylcholine receptors, reducing GI motility and secretions.
Mennium 10-4 is a combination of chlordiazepoxide, a benzodiazepine that enhances GABA-A receptor activity, and clidinium, an antimuscarinic that blocks muscarinic acetylcholine receptors.
Each tablet contains chlordiazepoxide HCl 5 mg and clidinium bromide 2.5 mg. Typical adult dose: 1-2 tablets orally 3-4 times daily before meals and at bedtime. Max 8 tablets daily.
Adults: 1 tablet (chlordiazepoxide 10 mg / clidinium 4 mg) orally 3 to 4 times daily before meals and at bedtime. Max: 4 tablets per day.
None Documented
None Documented
Chlordiazepoxide has a terminal elimination half-life of 5-30 hours (mean ~24 hours) in adults; its active metabolite desmethylchlordiazepoxide has a half-life of 10-30 hours. Accumulation occurs with repeated dosing. In elderly or hepatic impairment, half-life may be prolonged significantly. Clidinium has a half-life of 10-12 hours.
Chlordiazepoxide: 5-30 h (mean 20 h); clidinium: 10-20 h. Steady-state reached in 5-7 days.
Chlordiazepoxide is extensively metabolized in the liver to active metabolites (e.g., desmethylchlordiazepoxide, demoxepam). Renal excretion accounts for approximately 20% of unchanged drug; the remainder is excreted as metabolites in urine (80-90%) and feces (10-20%). Clidinium is excreted primarily unchanged in urine (75%) and feces (25%).
Renal (60% as unchanged chlordiazepoxide, 15% as conjugated metabolites; 5% biliary/fecal as metabolites)
Category D/X
Category C
Benzodiazepine
Benzodiazepine/Estrogen Combination